AquaBounty Technologies Inc. (AQB) is an innovative biotechnology company that specializes in aquaculture. The company, which is headquartered in Maynard, Massachusetts, USA, has pioneered and proven its proprietary technology that allows for year-round salmon farming in land-based facilities. Aligned with its commitment to a sustainable future, AquaBounty focuses on decreasing the environmental footprint of commercial-scale aquaculture and ensures the production of high-quality salmon.
AquaBounty's notable product includes the AquAdvantage Salmon. Engineered through a molecular technique, this signature fish grows year-round and matures faster under controlled environments compared to conventional salmon. Balance with ethical considerations, the production process is carried out in contained, inland farms that maximize biosecurity and minimize environmental impact. While still being fed conventional feeds, AquAdvantage Salmon has the benefit of reaching market size in a shorter time.
AquaBounty Technologies Inc. adheres to rigorous regulatory compliance imposed by the Food and Drug Administration (FDA). The approval received in 2015 turned the company to be the pioneer in genetically engineered (GE) fish available for consumption. Furthermore, sustainability is embedded in AQB's operations. The utilization of recirculating aquaculture systems (RAS) decreases ocean dependency while minimizing the environmental impact.
AquaBounty has shown an innovative approach to addressing some of the challenges facing current aquaculture, particularly the high cost, environmental impact, and sustainability issues related to traditional methods. The company's mission is to transform seafood production through genetics, biotechnology, and farming improvements. AquaBounty Technology is paving the way for the future of salmon aquaculture, firmly believing in the capability of sustainable technology and practices to establish a long-term solution to the growing global need for high-quality protein.
Its forward-thinking approach has garnered significant attention, with investors significantly backing the company in recent times. Despite the challenges of commercializing ground-breaking technology, AquaBounty's vision to benefit the world with fresher, responsibly sourced, and more sustainable seafood continues to propel the company forward.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
AquaBounty Technologies (NASDAQ: AQB) shares surged over 54% after the company announced an expansion of its strategic review for its Ohio campus to include AI data center and power infrastructure opportunities. The campus boasts a 50-megawatt substation, competitively priced electricity, and significant groundwater withdrawal permits, making it attractive for AI and high-performance computing needs. Despite this positive development, the company reiterated "going concern" doubts due to cumulative net losses and reliance on future capital raises.
AquaBounty Technologies Inc. (AQB) stock surged by 10.28% on heavy volume, attracting day traders due to its volatility and price action, despite the company's deep unprofitability and negative equity. The stock has been a speculative play, with recent intraday spikes providing opportunities for short-term traders to capitalize on momentum. While the company's fundamentals are weak, its price swings and liquidity make it appealing for disciplined trading strategies.
AquaBounty Technologies Inc. (AQB) stock surged by 9.35% due to favorable coverage of its GM salmon advancements, exhibiting extreme volatility with price swings from sub-$1 to over $1.60. Despite this speculative interest, the company faces significant financial challenges, including negative earnings, substantial debt, limited cash, and a highly negative analyst sentiment. For traders, AQB represents a high-risk, speculative opportunity driven by short-term momentum rather than fundamental strength.
AquaBounty Technologies Inc. (AQB) stock has surged by 17.76% due to positive news about its GMO salmon expansion, attracting day traders despite significant financial losses and negative equity. The stock is exhibiting classic low-float momentum action, with traders focusing on the $1.00-$1.20 range as a potential support level. While fundamentals are weak, fresh capital from preferred stock issuance is fueling volatile price movements, making AQB a speculative trading vehicle.
AquaBounty Technologies (NASDAQ: AQB) shares surged over 54% after hours following an announcement that the company is expanding its strategic review of its Ohio campus to include AI data center and power infrastructure opportunities. The company reported improved net losses for the quarter and first six months of the year but still faces substantial doubt about its ability to continue as a going concern due to cumulative net losses and dependence on further capital raises. AquaBounty’s Ohio campus possesses significant power capacity and groundwater withdrawal permits, making it attractive for high-performance computing needs.